Feline immunodeficiency virus subunit vaccines that induce virus neutralising antibodies but no protection against challenge infection

By Huisman W.   Karlas J.A.   Siebelink K.H.J.   Huisman R.C.   de Ronde A.   Francis M.J.   Rimmelzwaan G.F.   Osterhaus A.D.M.E.  

Vaccine, Vol. 16, Iss. 2, 1998-01 ,pp. : 181-187

Elsevier

Access to resources Recommend Favorite

Evaluation of subunit vaccines against feline immunodeficiency virus infection

By Stam J.G.   Verschoor E.J.   Willemse M.J.   van Vliet A.L.W.   Pouwels H.   Chalmers S.K.   Horzinek M.C.   Sondermeijer P.J.A.   Hesselink W.   de Ronde A.  

Vaccine, Vol. 14, Iss. 4, 1996-03 ,pp. : 285-289

Elsevier

Access to resources Recommend Favorite

DNA vaccination using expression vectors carrying FIV structural genes induces immune response against feline immunodeficiency virus

By Cuisinier A.M.   Mallet V.   Meyer A.   Caldora C.   Aubert A.  

Vaccine, Vol. 15, Iss. 10, 1997-07 ,pp. : 1085-1094

Elsevier

Access to resources Recommend Favorite

Mucosal immunization with experimental feline immunodeficiency virus (FIV) vaccines induces both antibody and T cell responses but does not protect against rectal FIV challenge

By Finerty S.   Stokes C.R.   Gruffydd-Jones T.J.   Hillman T.J.   Reeves N.A.   Whiting C.V.   Schaaper W.M.M.   Dalsgaard K.   Harbour D.A.  

Vaccine, Vol. 18, Iss. 28, 2000-08 ,pp. : 3254-3265

Elsevier

Access to resources Recommend Favorite

Protection against oronasal challenge with virulent feline leukaemia virus lasts for at least 12 months following a primary course of immunisation with Leukocell&unknown; 2 vaccine

By Harbour D.A.   Gunn-Moore D.A.   Gruffydd-Jones T.J.   Caney S.M.A.   Bradshaw J.   Jarrett O.   Wiseman A.  

Vaccine, Vol. 20, Iss. 23, 2002-07 ,pp. : 2866-2872

Elsevier

Access to resources Recommend Favorite